ClinicalTrials.Veeva

Menu

Modernizing Perinatal Syphilis Testing

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Enrolling

Conditions

Syphilis

Treatments

Diagnostic Test: Aptima Treponema pallidum transcription-mediated amplification (TMA) assay for detection of Treponema pallidum
Diagnostic Test: Quantitative polymerase chain reaction (qPCR) assay for detection of Treponema pallidum
Other: Center for Disease Control (CDC) Sexually Transmitted Infections (STI) 2021 Treatment Guidelines for diagnosis of syphilis

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06082453
R01HD108201 (U.S. NIH Grant/Contract)
HSC-MS-21-0731

Details and patient eligibility

About

Treponema pallidum is a bacterium that causes the disease syphilis. The primary objective of the study is to evaluate the testing performance of two diagnostic molecular techniques [quantitative polymerase chain reaction (qPCR) and transcription-mediated amplification (TMA)] for the detection of Treponema pallidum in maternal and neonatal specimens from participants with the diagnosis of syphilis using the Centers for Disease Control's (CDC's) Sexually Transmitted Infections (STI) Treatment Guidelines for adult and congenital syphilis.

Enrollment

924 estimated patients

Sex

All

Ages

Under 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Maternal diagnosis of syphilis by 2021 CDC STI guidelines, irrespective of treatment status; AND viable pregnancy with gestational age ≥ 12 weeks OR postpartum ≤ 96 hours from delivery
  • Neonates of pregnancies affected by syphilis ≤ 72 hours of birth

Exclusion criteria

  • Pregnant individuals and neonates who do not meet the criteria of syphilis (false positive)
  • Planning to move outside of study prior to ND testing

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

924 participants in 1 patient group

Molecular testing for detection of T. pallidum and use of CDC guidelines for diagnosis of syphilis
Experimental group
Treatment:
Other: Center for Disease Control (CDC) Sexually Transmitted Infections (STI) 2021 Treatment Guidelines for diagnosis of syphilis
Diagnostic Test: Quantitative polymerase chain reaction (qPCR) assay for detection of Treponema pallidum
Diagnostic Test: Aptima Treponema pallidum transcription-mediated amplification (TMA) assay for detection of Treponema pallidum

Trial contacts and locations

9

Loading...

Central trial contact

Irene Stafford, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems